MedTrace Logo

Feasibility Trial of EUS-PCA in IPMN Pancreatic Cysts

NCT06162468 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-04-23

No results posted yet for this study

Summary

The goal of this single-arm intervention trial is to determine the feasibility of implementing endoscopic ultrasound-guided pancreatic cyst chemoablation (EUS-PCA) using gemcitabine and paclitaxel for intraductal papillary mucinous neoplasms (IPMN) in two New Zealand tertiary interventional endoscopy centres.

Conditions

  • Intraductal Papillary Mucinous Neoplasm of Pancreas

Interventions

PROCEDURE

Endoscopic ultrasound-guided pancreatic cyst chemoablation (EUS-PCA) using gemcitabine and paclitaxel

EUS-PCA using gemcitabine and paclitaxel

Sponsors & Collaborators

  • Gut Cancer Foundation, New Zealand

    collaborator UNKNOWN

  • North Shore Hospital, New Zealand

    collaborator OTHER

  • Waikato Hospital

    collaborator OTHER

  • University of Auckland, New Zealand

    lead OTHER

Principal Investigators

  • Michael B Jameson, PhD · University of Auckland, New Zealand

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-31
Primary Completion
2026-06-30
Completion
2026-07-31

Countries

  • New Zealand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06162468 on ClinicalTrials.gov